Scientific Library of Tomsk State University

   E-catalog        

Image from Google Jackets
Normal view MARC view

Assessment of Preclinical Organ Damage in Hypertension electronic resource edited by Enrico Agabiti Rosei, Giuseppe Mancia.

Contributor(s): Agabiti Rosei, Enrico [editor.] | Mancia, Giuseppe [editor.] | SpringerLink (Online service)Material type: TextTextPublication details: Cham : Springer International Publishing : Imprint: Springer, 2015Description: VIII, 218 p. 44 illus., 28 illus. in color. online resourceContent type: text Media type: computer Carrier type: online resourceISBN: 9783319156033Subject(s): medicine | Health promotion | Angiology | Cardiology | Nephrology | Medicine & Public Health | Cardiology | Angiology | Nephrology | Health Promotion and Disease PreventionDDC classification: 616.12 LOC classification: RC681-688.2Online resources: Click here to access online
Contents:
PART I: HEART 1 Electrocardiography -- 2 Echocardiography -- 3 New techniques: 3D, CT, MRI -- PART II: LARGE ARTERIES 4 Ultrasound of Carotid IMT and plaque.- 5 Ultrasound of the Aorta/coronary arteries.- 6 Pulse wave velocity and central BP.- 7 Ankle-brachial index -- 8 Atherosclerosis and general principles of arterial imaging -- 9 Imaging and ageing of the aorta and large arteries in the lower extremities -- PART III: SMALL ARTERIES 10 Micro myography -- 11 Damage of the retinal arterioles -- 12 Capillaroscopy -- 13 Other techniques for assessment -- PART IV: KIDNEY 14 Proteinuria -- 15 Glomerular Filtration Rate -- 16 Other techniques -- PART V: BRAIN 17 RMN/TC: Evaluation of Brain damage -- 18 Questionnaires for cognitive function -- 19 Other techniques for neurological damage.- 20 Relation between blood pressure and markers of organ damage.
In: Springer eBooksSummary: This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

PART I: HEART 1 Electrocardiography -- 2 Echocardiography -- 3 New techniques: 3D, CT, MRI -- PART II: LARGE ARTERIES 4 Ultrasound of Carotid IMT and plaque.- 5 Ultrasound of the Aorta/coronary arteries.- 6 Pulse wave velocity and central BP.- 7 Ankle-brachial index -- 8 Atherosclerosis and general principles of arterial imaging -- 9 Imaging and ageing of the aorta and large arteries in the lower extremities -- PART III: SMALL ARTERIES 10 Micro myography -- 11 Damage of the retinal arterioles -- 12 Capillaroscopy -- 13 Other techniques for assessment -- PART IV: KIDNEY 14 Proteinuria -- 15 Glomerular Filtration Rate -- 16 Other techniques -- PART V: BRAIN 17 RMN/TC: Evaluation of Brain damage -- 18 Questionnaires for cognitive function -- 19 Other techniques for neurological damage.- 20 Relation between blood pressure and markers of organ damage.

This book presents up-to-date information on how to assess early preclinical alterations in the heart, the small and large arteries and the kidney in the general and the hypertensive population, using the most sensitive, specific and cost-effective techniques. A wide variety of techniques are discussed, with careful attention to the latest developments. For each organ, evidence is documented regarding the prevalence of organ damage. Information is provided on the potential induction of regression of organ damage by treatment, the criteria for establishing significant changes and the clinical prognostic significance of regression. The manual will be invaluable for all practitioners responsible for the clinical management of hypertensive patients, given that the assessment of early preclinical cardiovascular and renal damage permits more accurate risk stratification at baseline and facilitates evaluation of cardiovascular protection when regression of structural changes is achieved during treatment.

There are no comments on this title.

to post a comment.